Provided by Tiger Trade Technology Pte. Ltd.

HARBOR HEALTH CARE ETF

34.95
+0.18100.52%
Post-market: 34.950.00000.00%19:30 EDT
Volume:6K
Turnover:223.97K
Market Cap:44.56M
PE:- -
High:35.10
Open:35.10
Low:34.85
Close:34.77
52wk High:35.61
52wk Low:27.36
Shares:1.28M
Float Shares:1.28M
Volume Ratio:1.71
T/O Rate:0.50%
Dividend:0.08
Dividend Rate:0.22%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

PRIMECAP Management Co trims Eli Lilly stake by 50K

TIPRANKS
·
Aug 15

Rhythm Pharma EVP, Head of International Yann Mazabraud Sells USD 6.61 Million in Common Shares

Reuters
·
Aug 15

Insulet Corp. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 15

Eli Lilly & Co. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 15

Eli Lilly’s New Phase 1 Study Signals Ongoing Pipeline Expansion

TIPRANKS
·
Aug 15

Lilly Expands Obesity Pipeline With Fresh Macupatide Trial in Japan

TIPRANKS
·
Aug 15

Ascendis Pharma Reports Solid Yorvipath Quarter; Yuviwel Off to Strong Start, RBC Says

MT Newswires Live
·
Aug 14

Assembly Climbs on Quarterly Revenue Beat

Reuters
·
Aug 14

Mubadala Investment Co Pjsc Reports Share Stake in Ford Motor, Phillips 66, Dissolves in Apple

Reuters
·
Aug 14

Your Prescription Drugs Shouldn't Cost More than Your Mortgage. Inside the Broken Math That Got US Here.

Dow Jones
·
Aug 14

Ascendis Pharma is Maintained at Overweight by Barclays

Dow Jones
·
Aug 14

Ascendis Pharma (ASND) Receives a Buy from Cantor Fitzgerald

TIPRANKS
·
Aug 14

China Merchants Adjusts Eli Lilly Price Target to $1,252 From $964, Maintains Buy Rating

MT Newswires Live
·
Aug 14

RBC Adjusts PT on Ascendis Pharma to $290 From $280, Maintains Outperform Speculative Risk Rating

MT Newswires Live
·
Aug 14

Ascendis Pharma (ASND) Receives a Buy from Wells Fargo

TIPRANKS
·
Aug 14

UBS Pursues Dual Strategy in Q2: Betting on AI Compute Boom While Hedging Crowded Trade Risks

Stock News
·
Aug 14

Gilead Sciences (GILD) Gets a Hold from Barclays

TIPRANKS
·
Aug 14

Eli Lilly & Co (LLY) Gets a Buy from Barclays

TIPRANKS
·
Aug 14

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Ascendis Pharma (ASND)

TIPRANKS
·
Aug 14

Ascendis Pharma a/S : Jefferies Raises Target Price to $333 from $325

THOMSON REUTERS
·
Aug 14